Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma

Approaches aimed at enhancement of the tumor specific response have provided proof for the rationale of immunotherapy in cancer, both in animal models and in humans. Ipilimumab, an anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) antibody, is a new generation immunotherapeutic agent that has shown act...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosti, Giulio, Cocorocchio, Emilia, Pennacchioli, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804494/
https://www.ncbi.nlm.nih.gov/pubmed/24204168
http://dx.doi.org/10.2147/CCID.S24246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804494/
https://www.ncbi.nlm.nih.gov/pubmed/24204168
http://dx.doi.org/10.2147/CCID.S24246

Ejemplares similares